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ABSTRACT: The insulin/IGF-1 receptor is a major known determinant of dauer
formation, stress resistance, longevity, and metabolism in Caenorhabditis elegans. In the
past, whole-genome transcript proﬁling was used extensively to study diﬀerential gene
expression in response to reduced insulin/IGF-1 signaling, including the expression
levels of metabolism-associated genes. Taking advantage of the recent developments in
quantitative liquid chromatography mass spectrometry (LC−MS)-based proteomics,
we proﬁled the proteomic changes that occur in response to activation of the DAF-16
transcription factor in the germline-less glp-4(bn2);daf-2(e1370) receptor mutant.
Strikingly, the daf-2 proﬁle suggests extensive reorganization of intermediary
metabolism, characterized by the upregulation of many core intermediary metabolic
pathways. These include glycolysis/gluconeogenesis, glycogenesis, pentose phosphate
cycle, citric acid cycle, glyoxylate shunt, fatty acid β-oxidation, one-carbon metabolism,
propionate and tyrosine catabolism, and complexes I, II, III, and V of the electron
transport chain. Interestingly, we found simultaneous activation of reciprocally
regulated metabolic pathways, which is indicative of spatiotemporal coordination of energy metabolism and/or extensive
post-translational regulation of these enzymes. This restructuring of daf-2 metabolism is reminiscent to that of hypometabolic
dauers, allowing the eﬃcient and economical utilization of internal nutrient reserves and possibly also shunting metabolites
through alternative energy-generating pathways to sustain longevity.
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■ INTRODUCTION
In Caenorhabditis elegans, attenuation of the insulin/IGF-1
signaling (IIS) pathway during adulthood leads to signiﬁcant
changes in worm physiology, including extended life-span,
increased innate immunity and stress-resistance, and extensively
altered metabolism.1−13 These phenotypic adaptations rely, for
the most part, on the activation and nuclear translocation of the
forkhead box O (FOXO) transcription factor DAF-16, which
triggers an extensive genetic program that is normally
associated with an alternate developmental arrest state called
the dauer diapause.14−24
In mammals, insulin signaling plays a key role in the
regulation of energy metabolism.25 Disruption of the insulin
receptor in the brain is associated with expression of endocrine
neuropeptides that stimulate the uptake of food, leading to
obesity and symptoms of type II diabetes along with reduced
reproductive competence.26−29 In this respect, IIS in C. elegans
appears remarkably similar to mammalian insulin signaling in
that the nematode nervous system (together with the intestine)
was identiﬁed as a central regulator of daf-2-mediated energy
metabolism and longevity.30,154 Although disruption of IIS in
nematodes does not lead to any clear pathological conditions,
the conservation of this pathway in the regulation of fat and
carbohydrate metabolism as well as in life-span determination
from nematodes to mammals is at least striking.31−35 Therefore,
a thorough understanding of daf-2-speciﬁc metabolism and its
regulation, including species-speciﬁc peculiarities, may lead to
the discovery of novel metabolic pathways involved in insulin-
dependent pathologies or other fundamental processes such as
aging in humans.36,37
Whole-genome transcript proﬁling of daf-2 mutants and/or
dauers, using either microarray or SAGE analysis, has proven to
be successful at identifying diﬀerentially expressed gene sets
dependent on DAF-16, some of which are involved in energy
metabolism.14,16−20,22,23,38,39 However, reported transcript
proﬁles, especially with regard to energy metabolism, were
sometimes inconsistent between studies, complicating the
formulation of straightforward statements about IIS-mediated
metabolism.40,41 Moreover, the poor correlation between
Received: November 4, 2013
Published: February 20, 2014
Article
pubs.acs.org/jpr
© 2014 American Chemical Society 1938 dx.doi.org/10.1021/pr401081b | J. Proteome Res. 2014, 13, 1938−1956
mRNA transcript levels and actual protein abundances
necessitates great caution when drawing conclusions based
solely on interpreting transcript proﬁles.42,43
Proteomics analysis by Dong et al. of daf-2(e1370) mutants
has identiﬁed a limited set of enzymes in carbohydrate
metabolism (glycolysis/gluconeogenesis) as well as the TCA
and glyoxylate cycles that are diﬀerentially expressed in daf-2
mutants and showed that these enzymes are important
determinants of nematode life span. Recently, several groups
have published the ﬁrst metabolite proﬁles of the daf-2 mutant,
revealing signiﬁcant shifts in carbohydrate, amino acid, and lipid
metabolism, several of which were not apparent from
previously published transcriptomics studies.11−13 Although
these incentives contribute signiﬁcantly to the identiﬁcation of
altered metabolic pathways upon impaired IIS, an integrated
understanding of the metabolic restructuring and its impact on
worm physiology and longevity is still lacking.
Using LC−MS/MS-based proteomics analysis, we found that
activation of DAF-16 in the nucleus results in over-
representation of many enzymes of major, often reciprocally
regulated, metabolic pathways involved in the synthesis and
utilization of internal carbohydrate (glycolysis and gluconeo-
genesis), lipid stores (lipogenesis and lipolysis), amino acid
metabolism, and respiration (aerobic and anaerobic). In the
following sections, we integrate our proteomic data set together
with a selection of enzymatic activity assays, available literature,
and metabolomics data in an attempt to reconstruct and resolve
the intricacies of altered daf-2 metabolism.
■ MATERIALS AND METHODS
C. elegans Strains
The following strains were used in this study: NLGA154 glp-
4(bn2ts)I;daf-2(e1370)III (long-lived) and GA153 glp-4(bn2ts)I
daf-16(mgDf50)I;daf-2(e1370)III (reference strain), which were
kindly provided by David Gems at the University College of
London.39 The glp-4(bn2) background allele results in
germline-deﬁcient worms when grown at the nonpermissive
temperature of 24 °C. This allows for focusing on the proteome
of aging somatic cells, excluding the gonadal and complex
embryonic material.44 Previous lifespan analyses by McElwee et
al. and Tekipe and Alballay demonstrated that no increase in
lifespan results from the presence of the glp-4(bn2) allele in
otherwise wild-type or daf-16;daf-2 mutants grown on live
Escherichia coli.39,45 However, glp-4(bn2) causes a small but
signiﬁcant DAF-16-dependent extension of lifespan of daf-2
mutants and nematodes grown on killed E. coli.39,45 Previous
MS proteome proﬁling of glp-4(bn2) after 15N metabolic
labeling revealed only modest changes compared to the N2
wild-type.46 The RNAi-hypersensitive NL2099 rrf-3(pk1426) II
strain was used for RNAi lifespan analyses.
C. elegans Culturing and Sampling
The initiation and culturing of large age-synchronized
populations have been described in Depuydt et al.47 To
prevent glp-4 daf-16;daf-2 animals from becoming dauer larvae,
worms were grown at 16 °C until the third larval stage (L3)
and were then shifted to 24 °C for the remainder of the
experiment. Although shifting temperature at the L3 stage
rendered glp-4;daf-2 animals sterile, we noticed that by day 2 of
adulthood glp-4 daf-16;daf-2 mutants exhibited gonads with
incomplete morphogenesis, yet they were able to produce 2−4
eggs per animal. Therefore, we opted to add 5-ﬂuoro-2′-
deoxyuridine (FUdR, 75 μM fc., Acros Organics) to all mass
cultures in all biological replicates in order to maintain
complete sterility.
We note that the use of FUdR in light of recent reports
warrants caution, especially with regard to insulin/IGF-1
mutants.155−157 However, we argue that our data reﬂect bona
ﬁde metabolic changes in response to the daf-2 mutation. Our
results are in line and corroborate with the reported
metabolomics ﬁndings by Fuchs et al. who used both the daf-
2(e1370) and daf-2(m41) alleles without the use of FUdR in
their cultures.13 Also, the daf-2(e1370) proteomic ﬁngerprint
made by Dong et al. in the absence of FUdR identiﬁed a limited
number of diﬀerentially expressed enzymes in carbohydrate,
fatty acid, and amino acid metabolism whose expression pattern
was conﬁrmed in our study. A wealth of transcriptomics data is
available that show extensive changes in metabolic gene
expression upon DAF-16 activation in the absence of
FUdR.13−18,23 Although there is poor concordance between
these studies, our data correspond reasonably well with
reported microarray proﬁles (but it clashes with SAGE-
generated transcript proﬁles). We also note that the FUdR
concentration used by the Davies study is very high (400 μM,
compared to the more-than-suﬃcient 75 μM used in our
study), and the dose-dependency of FUdR was not been taken
into account.157 This 400 μM concentration, in our hands, is
borderline toxic for C. elegans.
For all experiments, samples were collected at day 2 of
adulthood and freed from dead animals, debris, and bacteria
through Percoll (Sigma-Aldrich) washing and ﬂotation on a
60% w/w sucrose solution. Animals were immediately ﬂash
frozen in liquid nitrogen and stored at −80 °C.
Proteomics Data Analysis
For comparing the metabolic proﬁle between long-lived glp-
4(bn2);daf-2(e1370) and reference glp-4(bn2) daf-16-
(mgDf50);daf-2(e1370) C. elegans worm strains, the accurate
mass and time (AMT) LC−MS proteomics data set was used,
which was published earlier by our group in Depuydt et al.47
and is freely available through PeptideAtlas48 at http://www.
peptideatlas.org/PASS/PASS00308 (see Supporting Informa-
tion ﬁle 1 for details). The same criteria as in Depuydt et al.47
were used to determine relative protein abundances, with the
exception of the following proteins that included redundant
peptides arising from diﬀerent expression isoforms of the same
gene: TPS-1, R11A5.4, W05G11.6, T22F3.3, MDH-1,
H24K24.3, GPD-1,-2,-3,-4, GPI-1, and ENOL-1.
Proteomics data was visualized with MeV (MultiExperiment
Viewer), part of the TM4 microarray software suite.49,50
Pavlidis template matching (PTM)51 was used to rank proteins
conforming to an expression pattern of interest. The PTM
algorithm allows a data set to be searched for proteins of which
the abundance proﬁle matches a user-deﬁned template proﬁle,
which is based on the Pearson correlation between the template
and the proteins in the data set.51The Kyoto Encyclopedia of
Genes and Genomes (KEGG) pathway52 and UniProt
Knowledgebase53 were used in conjunction with the process
of reconstructing the C. elegans metabolic network. Gene set-
enrichment analysis (GSEA) was used to determine whether
metabolic pathways show statistically signiﬁcant diﬀerential
expression as described in detail in Subramanian et al.54 In
short, a ranked list of proteins is generated according to their
diﬀerential abundance level between two experimental groups.
An enrichment score (ES) test statistic is calculated that reﬂects
the degree to which a deﬁned set of proteins is overrepresented
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at one of the extremes of the entire ranked list. Positive ES
values correspond with enrichment for enzymes ranked to have
higher expression levels in daf-2 mutants, whereas negative ES
values correspond with enrichment for enzymes ranked to have
lower expression levels. Gene sets eligible for GSEA are
reported with their nominal p value and false discovery rate
(FDR), calculated from 1000 permutations of the experimental
group labels. The nominal p value estimates the statistical
signiﬁcance of the ES for a single set. The FDR is the estimated
probability that an enriched set represents a false positive
ﬁnding. Subramanian et al. have suggested a FDR cutoﬀ of 25%
as appropriate to signify biologically signiﬁcant results.54 The
GSEA-P software used for GSEA can be found at the Broad
Institute’s Web site http://www.broadinstitute.org/gsea/index.
jsp.
Transmission Electron Microscopy (TEM)
Day 2 young adult glp-4(bn2) daf-16(mgDf50);daf-2(e1370)
and glp-4(bn2);daf-2(e1370) C. elegans nematodes were ﬁxed,
and transverse sections were taken according to Fonderie et
al.55 Electron microscopy was performed using a Jeol JEM 1010
(Jeol, Tokyo, Japan) operating at 60 kV. Digitizing of images
was performed using a DITABIS system (Pforzheim,
Germany).
Oil Red O Staining and Quantiﬁcation
Determination of relative fat content in individual worms by oil
red O staining was performed according to the protocol
described in O’Rourke et al.56 Brieﬂy, age-synchronized worms
were sampled at diﬀerent ages and washed in S-buﬀer (0.05 M
K2HPO4, 0.05 M KH2PO4, and 100 mM NaCl, pH 7.4).
Nematodes were ﬁxed in MRWB-buﬀer (160 mM KCl, 40 mM
NaCl, 14 mM Na2EGTA, 1 mM spermidine-HCl, 0.4 mM
spermine, 30 mM Na-PIPES, pH 7.4, and 0.2% β-
mercaptoethanol) containing 1% paraformaldehyde (PFA) for
1 h at room temperature with gentle stirring. Fixed worms were
stored at 4 °C until all samples were collected. Nematodes were
then washed with S-buﬀer (pH 7.4) to remove PFA and
incubated in 60% isopropanol for 15 min at room temperature
to dehydrate. Isopropanol was removed, and samples were
stained overnight in 60% oil red O stain (0.5 g/100 mL
isopropanol stock solution) with gentle stirring at room
temperature. After the dye was removed by washing in S-
buﬀer containing 0.01% triton, animals were mounted and
observed with a Reichert-Jung Polyvar light microscope and
imaged with an Olympus Camedia C-5050 digital camera.
Corel Photopaint (Corel Corporation, Ottawa, Canada) and
Fiji57 were used for image processing and analysis. In short, the
red channel of RGB images was converted to 8-bit grayscale,
and the resulting pixel values were inverted. A ﬁxed threshold
was set to remove remaining background artifacts. The density
per worm surface was then determined by calculating the
integrated density for each worm, normalized to the total worm
surface.
Enzymatic Assays
Equal amounts of worms were ﬂash frozen in liquid nitrogen
and stored at −80 °C. Worms were homogenized by bead
beating (glass beads 0.248−0.318 μm) in 50 mM sodium/
potassium phosphate buﬀer, pH 7.0, at 5000 strokes/min for 30
s. CHAPS was added at a 1% ﬁnal concentration to the
resulting homogenate, and the mixture was bead-beated again
for another 30 s. The mixture was kept on ice for 15 min and
centrifuged at 20 000 rcf for 8 min at 4 °C. The supernatant
was cleared by a second centrifugation step. The enzymatic
activities were assayed spectrophotometrically against the
appropriate blanks at 25 °C in microtiter plate wells using an
Inﬁnite M200 multiplate reader (Tecan, Man̈nedorf, Switzer-
land). Isocitrate lyase, pyruvate kinase, aconitase, and
phosphenolpyruvate carboxykinase activities were assayed as
described previously by Castelein et al.58 and references therein.
6-Phosphogluconic dehydrogenase activity was assayed accord-
ing to the method of Bergmeyer et al.59 following the
manufacturer’s instructions (Sigma no. P4553), with the
exception that only half of the described concentrations were
used for NADP and 6-phosphogluconate. Fumarase activity was
assayed following the protocol of Racker,60 with the exception
that only 8 mM sodium malate was used (ﬁnal concentration)
instead of the 50 mM in Racker’s work. Activity of 3-
hydroxyacyl-CoA dehydrogenase, catalyzing the conversion of
S-acetoacetyl-CoA to β-hydroxybutyryl-CoA with consequent
NADH consumption, was monitored according to the method
by Lynen et al.61 All enzyme activities were scaled to the
protein concentration of the worm extracts, estimated by the
bicinchoninic acid protein assay kit (Pierce, Rockford, IL,
USA).
■ RESULTS AND DISCUSSION
Functional annotation clustering62,63 of the proteomics data
set47 showed a signiﬁcant enrichment of proteins involved in
intermediary metabolism among long-lived glp-4(bn2);daf-
2(e1370) compared to reference glp-4(bn2) daf-16-
(mgDf50);daf-2(e1370) C. elegans worm strains (throughout
the text, we will refer to both strains as daf-2 and daf-16;daf-2,
respectively). During culturing of the worms, FUdR was used
to maintain complete sterility of the strains. Because the use of
FUdR in C. elegans aging studies warrants caution, we discuss
this issue in more detail in the Materials and Methods (C.
elegans culturing and sampling). Table 1 shows the result of
functional annotation clustering62,63 for entries in the KEGG
database category, which deals mainly with annotation of
intermediary metabolism genes.52 By searching the UniProt
Protein Knowledgebase53 and on the basis of the available
literature,19,22,23,64 we were able to reconstruct many of the
Table 1. Functional Annotation Clustering for KEGG
Pathway Terms Indicates a Signiﬁcant Enrichment of daf-2-
Upregulated Proteins Involved in Intermediary Metabolism
KEGG pathway term
number of
proteins EASE scorea
citrate cycle (TCA cycle) 14 2.6 × 10−8
valine, leucine, and isoleucine degradation 13 2.6 × 10−6
tyrosine metabolism 8 1.4 × 10−5
glycolysis/gluconeogenesis 10 2.9 × 10−5
oxidative phosphorylation 15 7.7 × 10−5
propanoate metabolism 9 3.0 × 10−4
pentose phosphate pathway 6 2.0 × 10−3
pyruvate metabolism 6 3.9 × 10−3
fatty acid metabolism 12 3,9 × 10−3
arginine and proline metabolism 6 1.3 × 10−2
fructose and mannose metabolism 6 2.5 × 10−2
tryptophan metabolism 8 3.0 × 10−2
lysine degradation 8 3.3 × 10−2
glyoxylate and dicarboxylate metabolism 3 4.1 × 10−2
aEASE score is a modiﬁed Fisher’s exact p value.63
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Figure 1. Carbohydrate and fermentative metabolism. (Left) Heat map of proteins that are part of carbohydrate and fermentative metabolism (base-
2 logarithmic scale). Each column represents one biological replicate (ﬁve for each condition). Red and green colors indicate a relative increase and
decrease in protein content for a particular protein, respectively (row). Numbers next to each heat map row denote fold change (linear) in
abundance for statistically signiﬁcant proteins. Proteins with signiﬁcantly changed abundance levels are denoted *, p < 0.05; **, p < 0.005; and ***,
p < 0.0005. Proteins are grouped according to whether protein proﬁles comply with a preset template as deﬁned by the Pavlidis template (PT)
matching algorithm (see Materials and Methods and ref 51). Green and red PT bars indicate lower and higher protein levels among strains,
respectively. Gray PT bars indicate protein proﬁles that do not match any obvious expression pattern (see Materials and Methods for details). Gene
set enrichment analysis (GSEA) allows for the assessment of whether a group of proteins (e.g., the set of genes that are part of carbohydrate
metabolism in our data set) shows statistically signiﬁcant diﬀerential expression as a whole (see Materials and Methods and ref 54 for more details).
ES, enrichment score from gene set enrichment analysis of the metabolic pathway; p, nominal p value of the ES; FDR, false discovery rate. FDR
should be ≤0.25 for the ES to be meaningful. (Right) Schematic overview of carbohydrate and fermentative metabolism. The color of protein names
matches their expression proﬁle (green, down; red, up; and black, not signiﬁcant). Single-headed arrows indicate physiologically irreversible
reactions. Green arrows depict the possible route of malate production via the reverse action of phosphoenolpyruvate carboxykinase and malate
dehydrogenase (see Results and Discussion). Inset bar graphs represent relative enzyme activity of phosphoenolpyruvate carboxykinase (PEPCK)
and pyruvate kinase (PK). (1) Glycogen synthase, (2) glycogen phosphorylase, (3) hexokinase/glucokinase, (4) phosphohexoseisomerase, (5)
phosphofructokinase, (6) fructose-1,6-bisphosphate, (7) aldolse, (8) triose phosphate isomerase, (9) glyceraldehyde-3-phosphate dehydrogenase,
(10) phosphoglycerate kinase, (11) phosphoglycerate mutase, (12) enolase, (13) pyruvate kinase, (14) pyruvate dehydrogenase complex (E1,
pyruvate dehydrogenase; E2, dihydrolipyl transacetylase; and E3, dihydrolipoyl dehydrogenase), (15) pyruvate carboxylase, (16) mitochondrial/
cytosolic malate dehydrogenase, (17) malate-α-ketoglutarate antiporter (malate shuttle), (18) phosphoenolpyruvate carboxykinase, (19)
phosphoglycerate dehydrogenase, (20) lactate dehydrogenase, (21) alcohol dehydrogenase, (22) aldehyde dehydrogenase, (23) acetyl-CoA
synthetase, and (24) trehalose-6-phosphate synthase. Glu-6P, glucose-6-phosphate; Fru-6P, fructose-6-phosphate; Fru-1,6-BP, fructose 1,6-
bisphosphate; DHAP, dihydroxyacetone phosphate; G3P, glyceraldehyde-3-phosphate; 3PG, 3-phosphoglycerate; PEP, phosphoenolpyruvate; and
OOA, oxaloacetate.
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pathways in C. elegans intermediary metabolism from our data
set, which is the focus of this article.
Increased Expression of Most Carbohydrate Metabolism
Enzymes in daf-2
We detected increased protein abundance of many glycolytic
enzymes in daf-2 mutants, including hexokinase (H25P06.1)
and phosphofructokinase (Y71H10A.1), two major regulatory
sites of glycolysis that catalyze irreversible reactions (Figure 1).
The only exception occurs in the ﬁnal (irreversible) step in
glycolysis catalyzed by the pyruvate kinase enzymes PYK-1 and
PYK-2, which remain unaltered in daf-2 mutants. We also ﬁnd
increased protein expression of enzymes in gluconeogenesis:
fructose-1,6-bisphosphatase (FBP-1), pyruvate carboxylase
(PYC-1), and two isoforms of phosphoenolpyruvate carbox-
ykinase (PEPCK), R11A5.4 and W05G11.6. PEPCK con-
stitutes a key activator of gluconeogenesis,65 and elevated levels
of PEPCK in daf-2 mutants conﬁrm earlier reports on PEPCK
transcript and protein levels in insulin/IGF-1 signaling-
defective mutants.66,67 Simultaneous activation of glycolysis
and gluconeogenesis would lead to a futile cycle, generating
heat at the cost of ATP hydrolysis. This seems unlikely because
daf-2 mutants have lower mass-speciﬁc thermogenesis and both
pathways are reciprocally regulated.64,68 To investigate the
relative activities of glycolysis/gluconeogenesis, we measured in
vitro enzymatic activities of PEPCK (gluconeogenesis) and
pyruvate kinase (glycolysis) (Figure 1). Surprisingly, in stark
contrast with the more than doubled PEPCK enzyme levels,
relative PEPCK enzymatic activity in daf-2 mutants was only
50% compared to the daf-2;daf-16 reference, indicating that
gluconeogenesis in young adult daf-2 mutants is repressed. In
contrast, pyruvate kinase activity remains unchanged in the daf-
2 mutant, suggesting normal glycolysis activity.
We also found signiﬁcantly elevated protein levels of both
glycogen synthase-1 (GSY-1/Y46G5A.31, glycogenesis) and
the orthologue of human glycogen phosphorylase (T22F3.3,
catalyzing the ﬁrst step in glycogenolysis) in daf-2 adults
(Figure 1). Ultrastructural and biochemical studies showed daf-
2 mutants and dauers store signiﬁcantly more glycogen in their
intestinal and hypodermal cells compared to wild-type
nematodes.69,70 Electron micrographs taken from our samples
also conﬁrmed the presence of high amounts of glycogen in
hypodermal cells and body-wall muscles of daf-2 mutants
(Figure 2), consistent with increased glycogen synthase activity.
The fermentation of stored glycogen constitutes a major source
of energy during anoxia/hypoxia and is determinate for
nematode survival under these conditions.69,71 Consistently,
the increased survival of daf-2 mutants during anoxic insult is
dependent on its high glycogen levels.8,69 In addition, in dauer
larvae, high glycogen reserves likely serve to maintain their high
degree of motility during the ﬁrst few weeks after dauer
formation,72 which is in agreement with the expression of
glycogen phosphorylase in C. elegans muscles.73
We found signiﬁcantly increased protein levels of TPS-1, one
of two C. elegans trehalose-6-phosphate synthase genes
responsible for trehalose biosynthesis, consistent with increased
trehalose levels in IIS-defective C. elegans mutants and
dauers13,74,75 and DAF-16-dependent transcription regula-
tion.16,17,76 Importantly, tps-1 and tps-2 were found to be
required, in part, for daf-2 longevity.74 Besides its role in
carbohydrate storage and transport,77,78 trehalose also has
extensive cytoprotective functions, most probably by stabilizing
the proteome and lipid membranes under various stress
conditions, including cold, heat, dehydration, hypoxic, and
oxidative insult.79−81 Elevated levels of trehalose are associated
with life-span extension in C. elegans74 and also render daf-2
dauers resistant to extreme desiccation.81
Figure 2. Transmission electron microscopy images of transversal midbody cross sections of day 2 adult nematodes. (Left) daf-2 mutants exhibit
relatively large amounts of glycogen (delineated in green) and fat droplets (orange arrowhead) stored inside hypodermal and intestinal cells
compared to the reference strain. daf-2 mutants also show a smaller cross-sectional diameter compared to the daf-16;daf-2 reference. Quantitative
determination of worm length, diameter, and volume of both daf-2 and daf-2;daf-16 worms is shown in Supporting Information ﬁle 2. (Right) High-
magniﬁcation image (×25 000) of a small section of daf-2 striated muscle tissue showing the tight organization of glycogen and mitochondria close
to the myoﬁlament lattice.
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Pentose Phosphate Pathway Enzymes Are Upregulated in
daf-2
Our data show a signiﬁcant upregulation in the expression of
three enzymes predicted to be part of the pentose phosphate
pathway, including GSPD-1, the C. elegans orthologue of
glucose-6-phosphate dehydrogenase (G6PDH), which catalyzes
the ﬁrst step in the pentose phosphate pathway and converts
NADP+ into NADPH (Figure 3). However, we found no
signiﬁcant diﬀerence in the activity of this pathway by
measuring the enzymatic activity of 6-phosphogluconate
dehydrogenase (Figure 3). Nonetheless, temporal activation
of this pathway could be involved in the increased oxidative
stress resistance of the daf-2 mutant because the rerouting of
carbohydrate intermediates from glycolysis to the pentose
phosphate shunt has been shown to be part of a coordinated
response to oxidative stress by maintaining high cytoplasmatic
NADPH/NADP+ ratios in C. elegans, Drosophila, and
mammals.82−86
Activation of Alcohol Fermenting Enzymes in daf-2
A strong upregulation was found of several putative alcohol
dehydrogenases and aldehyde dehydrogenases involved in
alcohol metabolism (Figure 1). Alcohol dehydrogenases
include the predicted sorbitol dehydrogenases SODH-1 and
its homologue R04B5.5, the ribitol-dehydrogenase domain
containing protein F20G2.2.19,87 The actual substrate of these
alcohol dehydrogenases is unknown at present, but sodh-1
appears capable of metabolizing ethanol.88 SODH-1 is known
to be activated by DAF-16,17,19,89 and higher mRNA levels of
sodh-1 were also found in long-lived worms cultured axeni-
cally.58 Furthermore, SODH-1 was the most upregulated
(1200%) spot in 2D-DIGE gels from Staphylococcus aureus-
treated worms but not in Aeromonas hydrophila-treated
worms.90,91 Therefore, the biological role of this enzyme may
reach further than fermentative metabolism. Indeed, some
alcohol dehydrogenase enzymes are also capable of neutralizing
cytotoxic aldehydes originating from lipid peroxidation,
including 4-hydroxynonenal (4-HNE).92,93
ALH-1 is an orthologue of mitochondrial aldehyde
dehydrogenase 2 in humans that possibly catalyzes the
conversion of acetaldehyde, resulting from the oxidation of
ethanol, into acetate. Although we found strongly increased
abundance of ALH-1 in daf-2 mutants, metabolomic proﬁles of
daf-2 mutants indicate a signiﬁcant drop in acetate content in
IIS mutants.13 ALH-1 is also involved in the detoxiﬁcation of
toxic aldehyde byproducts of alcohol metabolism or lipid
peroxidation.94,95 More speciﬁcally, C. elegans ALH-1 was
shown capable to oxidize 4-HNE further to the lesser reactive
4-HNA (4-hydroxynon-2-enoic acid), similar to mammalian
aldehyde dehydrogenase.96 On the basis of these reports, the
activation of alcohol-fermenting enzymes in daf-2 mutants may
well be part of a coordinated stress response system that boosts
the nematodes resistance to toxic byproducts of lipid and
intrinsic alcohol metabolism.
Most Citric Acid Cycle Enzymes Are Upregulated in daf-2
Mutants
A general increase was found of the citric acid cycle enzymes,
including citrate synthase, the isocitrate dehydrogenase
complex, and the α-ketoglutarate dehydrogenase complex,
Figure 3. Pentose phosphate pathway. (Right) Heat map (base-2 logarithmic scale) and (left) schematic overview of proteins that are part of the
pentose phosphate pathway. Numbers next to each heat map row denote fold change (linear) in abundance for statistically signiﬁcant proteins.
Proteins with signiﬁcantly changed abundance levels are denoted *, p < 0.05; **, p < 0.005; ***, p < 0.0005. (1) Glucose-6-phosphate
degydrogenase, (2) gluconolactone hydrolase, (3) 6-phosphogluconate dehydrogenase, (4) ribulose-5-phosphate-3-epimerase, (5) ribose-5-
phosphate-ketoisomerase, (6) transketolase, (7) transaldolase, and (8) ribokinase. Inset bar graph represents relative enzyme activity of 6-
phosphogluconate dehydrogenase (6PGDH).
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which was the main sites of regulation within this cycle (Figure
4). This increase is accompanied with higher activity of
fumarase and aconitase in vitro (Figure 4). Transcript proﬁles
of daf-2 mutants did not show any signiﬁcant change in mRNA
levels for citric acid cycle enzymes.23,24 Expression of these
genes therefore may be regulated post-transcriptionally or be
the result of lowered turnover of these enzymes or the
mitochondria in which they reside. Here, daf-2 energy
metabolism appears to diﬀer from that of the dauer larva,
which is characterized by both reduced gene expression and
enzymatic activity of citric acid cycle genes.22,97,98 We note that
the aconitase, ACO-1, is downregulated in daf-2 mutants.
However, ACO-1 is thought to be a cytosolic aconitase
involved in the regulation of cellular iron concentrations and is
therefore not part of the citric acid cycle.99 Similarly, IDH-1 is a
predicted cytosolic NADP-dependent isocitrate dehydrogenase
(IDH) and shows no upregulation in daf-2.23 We note here that
cytosolic NADP-dependent IDH activity is strongly increased
in the daf-2 mutant (data not shown).
daf-2 Glyoxylate Shunt Is Activated, as in Dauers
The glyoxylate shunt allows the synthesis of carbohydrates via
gluconeogenesis from acetyl-CoA obtained from fatty acid β-
oxidation and is generally known in plant and microorganism
biochemistry. Nematodes also have been shown to contain an
active glyoxylate shunt,100,101 which is required for the full
longevity phenotype of daf-2 and several ETC-defective
mutants (Mit mutants) as well as the mitochondrial mutant
clk-1(qm30).17,102,103 In C. elegans, the key glyoxylate cycle
enzymes, isocitrate lyase and malate synthase, are contained as
two separate structural domains in a single protein, ICL-1.104
Figure 4. Mitochondrial intermediary metabolism. (Left) Heat map (base-2 logarithmic scale) and (right) schematic overview of enzymes in
mitochondrial intermediary metabolism. Numbers next to each heat map row denote fold change (linear) in abundance for statistically signiﬁcant
proteins. Proteins with signiﬁcantly changed abundance levels are denoted *, p < 0.05; **, p < 0.005; and ***, p < 0.0005. Inset bar graphs represent
relative enzymatic activities of aconitase, fumarase, and isocitrate lyase. (1) Pyruvate dehydrogenase complex, (2) citrate synthase, (3) aconitase, (4)
isocitrate dehydrogenase complex, (5) α-ketoglutarate dehydrogenase complex (E1, oxoglutarate dehydrogenase; E2, dihydrolipoyl succinyl
transferase; and E3, dihydrolipoyl dehydrogenase), (6) succinate thiokinase, (7) succinate dehydrogenase, (8) fumarase, (9) malate dehydrogenase,
(10) pyruvate carboxylase, (11) isocitrate lyase, (12) malate synthase, (13) mitochondrial tri/dicarboxylate carrier protein, (14) GDH-1, glutamate
dehydrogenase; W07E11.1, glutamate synthase, (15) malate-α-ketoglutarate antiporter (malate shuttle), and (16) aspartate aminotransferase. Succ,
succinate; succ-CoA, succinyl-CoA; ACO, aconitase; and FUM, fumarase.
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We observed a very strong increase in ICL-1 abundance,
consistent with previous transcriptional evidence.17,22,23 Con-
sistently, in vitro activity of both isocitrate lyase and malate
synthase is increased in daf-2 (Figure 4) and age-198 mutants,
respectively.
Major Shift in One-Carbon Metabolism in daf-2
One-carbon metabolism involves the storage and utilization of
one-carbon moieties in anabolic and transmethylation-based
regulatory pathways.105 The carrier of activated one-carbon
fragments is tetrahydrofolate (THF), an essential water-soluble
derivative of vitamin B9 involved in the formation of
nucleotides for DNA synthesis, the metabolism of certain
amino acids, and the source of methyl groups for S-adenosyl
methionine (SAM).106 A particularly strong increase was found
in the protein levels of the putative C. elegans AICAR
formyltransferase (C55F2.1) and C1-THF synthase
(K07E3.4) in daf-2, both of which are involved in the
interconversion of one-carbon derivates of THF (Figure 5).
Serine is the major donor of one-carbon in the form of N5,N10-
CH2-THF through its catabolism via glycine.
107 We found
increased levels in the daf-2 mutant of phosphoglycerate
dehydrogenase (C31C9.2), which catalyzes the ﬁrst step in
glucose-derived serine biosynthesis, and F25B4.1, the C. elegans
orthologue of the glycine cleavage system T-protein, an
aminomethyltransferase that catalyzes the actual transfer of
methylene carbon from the decarboxylated glycine to
tetrahydrofolate (THF). Taken together, our results suggest
changes in THF-based anabolism in daf-2 mutants, possibly
fueled via de novo synthesis of serine and subsequent oxidation
over glycine to supply one-carbon units.
In contrast to THF-metabolism, the biosynthetic pathway of
SAM, the other main carrier for single-carbon units, appears
repressed in daf-2 mutants (Figure 5). S-adenosylmethionine
synthase activity produces SAM by catalyzing the condensation
of methionine with ATP. Protein levels of this enzyme (SAMS-
1) are strongly reduced in the daf-2 mutant. Demethylation of
SAM results in the production of S-adenosylhomocysteine
(SAH), which is a strong inhibitor of all SAM-dependent
transmethylation reactions.108 S-adenosylhomocysteinase cata-
lyzes the hydrolytic cleavage of SAH into homocysteine plus
adenosine, but expression of this enzyme (AHCY-1) at the
protein level also appears signiﬁcantly reduced in daf-2 mutants.
Homocysteine lies at the cross-point of two competing
pathways: it is either used to form methionine (for SAM
synthesis) via the remethylation pathway or to form cysteine via
the transsulfuration pathway.108 Transsulfuration of homocys-
teine to cysteine is catalyzed by two enzymes: cystathione β-
synthase (CBS), which forms cystathionine from homocysteine
and serine, and cystathionine γ-lyase, which converts
cystathionine to cysteine, α-ketobutyrate, and ammonia. The
putative C. elegans orthologue of CBS (K10H10.2) is strongly
upregulated in daf-2, suggesting increased funneling of
homocysteine toward cysteine synthesis, away from remethy-
lation of homocysteine into methionine. Because cysteine is
normally readily available from diet, the major role of the
transsulfuration pathway in animals is thought to be the
regulation of SAM levels by controlling methionine/homo-
cysteine degradation and not cysteine biosynthesis per se.109
Thus, high CBS activity in daf-2 mutants is an additional strong
indication of repressed SAM synthesis. In contrast, the putative
C. elegans cystathionine γ-lyase orthologue CTH-1 is down-
regulated, and its paralogue, CTH-2, shows no change in
expression. Because there is no apparent alternate route for the
further processing of cystathionine, it seems that reduced CTH-
1 expression aims to temper the increased ﬂux through CBS.
Taken together, our data strongly suggest a reduced ﬂux
through the methyl cycle in daf-2 mutants.
Figure 5. One-carbon pool metabolism. (Right) Heat map (base-2 logarithmic scale) of enzymes part of C. elegans one-carbon metabolism. (Left)
Shematic overview of one-carbon metabolism involving both the single-carbon carriers tetrahydrofolate and S-adenosylmethionine. Numbers next to
each heat map row denote fold change (linear) in abundance for statistically signiﬁcant proteins. Proteins with signiﬁcantly changed abundance levels
are denoted *, p < 0.05; **, p < 0.005; and *** p < 0.0005. (1) Phosphoglycerate dehydrogenase (C31C9.2), phosphoserine aminotransferase
(F26H9.6), (2) serine hydroxymethyl transferase, (3) glycine cleavage system T-protein (aminomethyltransferase), (4) AICAR formyltransferase
(C55F2.1), C1-THF-synthase (K07E3.4), (5) S-adenosyl methionine synthase, (6) methionine synthase, (7) S-adenosylhomocysteinase, (8 and 10)
cystathionine β-synthase/cysteine synthase, and (9) cystathionine γ-lyase. THF, tetrahydrofolate.
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Adult daf-2 Mutants Show Increased Reliance on Internal
Fat Stores
In mammals, fatty acid synthesis is initiated by citrate transport
across the mitochondrial membranes into the cytoplasm via
tricarboxylate carriers (TIC) in exchange with malate.110 Once
in the cytosplasm, citrate is cleaved by ATP-citrate lyase (ACL)
into acetyl-CoA and oxaloacetate.111 This enzyme is the main
source for cytosolic acetyl-CoA for fatty acid synthesis and
represents a major link between the citric acid cycle and
lipogenesis.111 In mammals, expression of this mitochondrial
citrate carrier is activated by insulin signaling,110,112 and
inhibition of ACL was shown to reduce fatty acid synthesis
signiﬁcantly and to increase fatty acid β-oxidation.113 We found
strongly increased abundance of the C. elegans mitochondrial
TIC (K11H3.3) and ACL (D1005.1) in daf-2 mutants
compared to the reference strain, suggesting increased
lipogenesis (Figure 6B). Paradoxically, we found a strong
suppression of the predicted C. elegans fatty acid synthase,
FASN-1, in daf-2 adults. This suggests that in adult daf-2 worms
fatty acid synthesis is attenuated even in the presence of plenty
of substrates. We note that the C. elegans genome contains at
least three other putative fatty acid synthase genes (C41A3.1,
F10G8.9, and F32H2.6), which could also be important
determinants of fatty acid synthesis.
Figure 6. Fatty acid metabolism. (A) Synthesis of fatty acids. (Right) Heat map and (left) schematic overview of enzymes implicated in fatty acid
synthesis. (1) Citrate synthase, (2) mitochondrial tricarboxylate/dicarboxylate carrier protein (citrate transport protein), (3) ATP-citrate lyase, and
(4) FASN-1, fatty acid synthase; ELO-1, long-chain fatty acid elongase; DHS-25, mitochondrial beta-ketoacyl-ACP reductase; FAT-6 and FAT-2
encode fatty acyl desaturases. 3-HADH, 3-hydroxyacyl-CoA dehydrogenase. (B) Oxidation of fatty acids. (Right) Heat map and (left) schematic
overview of detected fatty acid β-oxidation enzymes. Numbers next to each heat map row denote fold change (linear) in abundance for statistically
signiﬁcant proteins. Proteins with signiﬁcantly changed abundance levels are denoted *, p < 0.05; **, p < 0.005; and ***, p < 0.0005. Inset bar graph
represent relative enzymatic activity of acyl-CoA dehydrogenase. (1) Acyl-CoA synthetase, (2) carnitine O-acyltransferase, (3) acyl-CoA
dehydrogenase, (4) trans-2-enoyl-CoA hydratase, (5) 3-hydroxyacyl-CoA dehydrogenase, (6) thiolase, (7) acetyl-CoA acetyltransferase (thiolase),
(8) 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) lyase, and (9) succinyl-CoA-acetoacetate CoA transferase.
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At the same time, we found increased expression in daf-2
adults of many fatty acid β-oxidation proteins (Figure 6A) as
well as an enzyme involved in glycerol catabolism (T24G3.4)
and a choline/carnitine palmitoyl transferase (B0395.3). The
latter is possibly responsible for the translocation of long-chain
fatty acids into the mitochondrial matrix prior to oxidation. We
also found increased protein levels of MAOC-1, a predicted
peroxisomal fatty acid β-oxidase enzyme. To assess whether
fatty acid β-oxidation is increased in the daf-2 mutant, we
measured the in vitro activity of 3-hydroxyacyl CoA
dehydrogenase, which catalyzes the oxidation of L-3-hydrox-
yacyl CoA, and found that its activity was unchanged (Figure
6). Nonetheless, the coordinated upregulation of most β-
oxidation enzymes clearly indicates that daf-2(e1370) worms
tend to rely more on internal fat stores compared to wild type
to fuel their energy needs. The formed acetyl-CoA is either
further oxidized to CO2 and water in the citric acid cycle or,
alternatively, acetyl-CoA is converted into succinate and malate
via the upregulated glyoxylate cycle for use in gluconeogenesis.
In addition, glyceraldehyde-3-phosphate derived from the
catabolism of glycerol can be fed into the glycolytic pathway
for energy generation. We note that the relative increase in β-
oxidation proteins found in our study appears not to be
reﬂected at the transcript level, as both SAGE- and microarray-
based transcript proﬁling detected no change in the mRNA
expression of β-oxidation enzymes in daf-2 mutants.18,23
On the basis of our results, we hypothesize that daf-2
mutants switch from fat synthesis and storage during
development and early adulthood to controlled lipid break-
down for the remainder of life, mimicking the dauer larva.114
To test this hypothesis, we determined the age-dependent
alterations in fat content of daf-2 mutants and daf16;daf-2
reference worms by staining with the fat-soluble dye oil red O
(Figure 7).56 We combined these results with data on the
feeding behavior of the same IIS mutants (but lacking the glp-4
mutation) collected over many aging series that were run
independently in liquid cultures in our lab. As expected, our
data show that daf-2 mutants accumulate signiﬁcantly more fat
than the daf-16;daf-2 reference at day 2 of young adulthood.
Although we noticed a sudden drop in oil red O intensity at day
6 of adulthood, daf-2 mutants were able to maintain relatively
high fat content, whereas in reference worms, fat levels
decreased steadily with age. This result is remarkable given
that daf-2(e1370) mutants exhibit a clear Eat phenotype
(reduced food uptake) that manifests itself during early
adulthood (Figure 7). Therefore, daf-2 fat metabolism is
reminiscent to the nonfeeding dauer larva, which depends on
the slow and controlled release of energy and anabolic
intermediates via β-oxidation of internal fat stores for its
survival.22,72,114−116
daf-2 Mutants May Catabolize Their High Propionate
Levels
The daf-2 mutant has been shown to contain increased levels of
propionate.13 The carbon atoms of propionate are recycled into
the citric acid cycle component succinyl-CoA via an evolu-
tionary conserved multienzyme pathway that was shown to be
fully functional in C. elegans (Figure 8).117,118 We detected
signiﬁcantly increased abundance of the propionate catabolic
enzymes methylmalonyl-CoA racemase (MCE-1), methylma-
lonyl-CoA mutase (MMCM-1), and the alpha (PCCA-1) and
beta (PCCB-1) subunits of propionyl-CoA decarboxylase in
daf-2 adult animals (Figure 8).
Propionate is either activated to propionyl-CoA by an
appropriate acyl-CoA synthetase or originates directly from the
catabolism of the branched amino acids valine and isoleucine or
β-oxidation of odd-chain-length fatty acids.64 Activation of this
catabolic pathway would thus indicate increased catabolism of
fatty acids or branched chain amino acids in the daf-2 mutant.
Amino Acid Catabolism May Replenish the TCA Cycle in
the daf-2 Mutant
Recent metabolomic proﬁling studies of the daf-2 mutant have
revealed an increase in the concentration of free amino acids, in
particular of branched-chain amino acids (BCAAs), suggesting
altered amino acid metabolism in this mutant.12,13 In
accordance, we report an increase in the level of glutamate
dehydrogenase (GDH-1), an enzyme essential in amino acid
breakdown that catalyzes the deamination of glutamate into α-
ketoglutarate (Figure 4). We also ﬁnd a dramatic increase
(16.6-fold) in the putative glutamate synthase W07E11.1,
which catalyzes the formation of glutamate from glutamine. In
mammals, glutamine serves as a universal transporter of
nitrogen and is the most common free amino acid in human
blood plasma. Interestingly, Martin et al. showed that the level
of glutamine and glutamate were increased and decreased,
respectively, in the daf-2 mutant.12 We speculate that the strong
increase of glutamate synthase in combination with glutamate
dehydrogenase is indicative of increased amino acid catabolism
in the daf-2 mutant, fueling the TCA cycle.
Also consistent with increased amino acid catabolism is the
clear increase of most tyrosine catabolic enzymes, including
HPD-1 (Figure 9a).119 Our result is consistent with an earlier
proteomics report where fumarylacetoacetate hydrolase
(K10C2.4) was found to be signiﬁcantly upregulated in the
daf-2 mutant.67 Moreover, the transcript level of cytosolic
tyrosine aminotransferase (TAT, F24D1.2), which catalyzes the
ﬁrst step in tyrosine catabolism, was found to be highly
enriched in dauers.19
Figure 7. Age-related change in fat content and feeding behavior.
Nematodes were stained with oil red O to determine the relative fat
content in individual worms. For each time point, between 10 and 22
nematodes were analyzed per strain. The amount of E. coli in grams
required each day to maintain a constant turbidity (OD550 = 1.8) in
culture medium (liquid cultures) was used as a measure to assess the
feeding behavior as a function of age. We note that zero values for oil
red O intensity do not indicate that these animals are devoid of fat but
merely indicate the detection limit of this dye for quantifying fat levels.
Green arrowhead represents time of sampling for proteomics analysis.
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The level of cellular tyrosine is thought to be determined by
insulin signaling through modulation of tyrosine catabo-
lism.19,120 Like in mammals, C. elegans TAT and the
gluconeogenic enzyme PEPCK both contain an insulin-
responsive element (IRE) in the promoter region, conferring
insulin-induced inhibition of expression. Thus, rather surpris-
ingly and in contrast with our and others proteome data,67
reduced insulin signaling in C. elegans has been associated with
the transcriptional repression of tyrosine catabolic enzyme hpd-
1.15 This discrepancy between transcript and protein levels
indicates complex regulation of tyrosine catabolism enzymes.
In contrast to tyrosine, we found reduced concentrations of
BCAA catabolic enzymes, including the branched-chain amino-
transferase enzyme (BCAT-1), in the daf-2 mutant (Figure 9b),
in line with transcriptional evidence and paralleled by increased
levels of BCAAs as reported previously by us47 and others.12,13
Finally, we also found increased abundance of the aspartate
aminotransferases T01C8.5 and C14F11.1 (Figure 4), which
catalyze the interconversion of aspartate and α-ketoglutarate
into oxaloacetate and glutamate.
Complexes of the daf-2 Electron Transport Chain Are
Diﬀerentially Regulated
An increased protein level of several subunits of complexes I
and II and to a lesser extent complexes III and V was found in
daf-2 mutants (Figure 10). Remarkably, protein expression of
cytochrome C oxidase (complex IV) was repressed in daf-2.
Cytochrome C oxidase catalyzes the terminal reduction of one
O2 molecule to two molecules of H2O with the additional
translocation of four protons to the intermembrane space. If
complex IV activity is reduced in daf-2 animals, then it can be
expected that less oxygen is consumed compared to wild type.
A slightly reduced mass-speciﬁc metabolic rate, as measured by
carbon dioxide gas respirometry, has been reported in daf-2
mutants.121 However, no decrease in oxygen consumption
between daf-2(e1370) and wild-type or daf-16(m26);daf-
2(e1370) has been observed in locomotory active
worms.10,68,122 Carbon dioxide gas respirometry is expected
to leave the worms practically undisturbed on a spot of E. coli
bacteria,121 whereas direct oxygen consumption measurements
in liquid require extensive stirring, stimulating worm movement
and thus metabolic activity, which could explain the discrepancy
in reported daf-2(e1370) metabolic rates.10 In addition, adult
daf-2 mutants cultured on undisturbed agar plates appear to be
rather inactive when compared to the reference strain,123,124
but they retain the ability to move freely in response to, for
example, mechanical stimulation, similar to dauers.125 daf-2
mutants are also characterized by reduced food uptake (as was
discussed earlier) and low heat output.10 Therefore, we suggest
that daf-2 standard metabolism, like dauers, is hypometabolic,
but the metabolic rate is readily raised when necessary, and this
is ensured by the availability of large amounts of fat and
glycogen and the increased levels of enzymes of core
intermediary metabolism.
We also found elevated protein levels of the electron-
transferring ﬂavoproteins (ETF) F27D4.1 and ETF-dehydro-
genase (LET-721) in daf-2 mutants, although the latter
upregulation was not statistically signiﬁcant. These proteins
transfer the electron pair of FADH2, resulting from the β-
oxidation of acyl-CoA, to the ﬂavo-iron−sulfur protein ETF-
dehydrogenase, which in turn reduces coenzyme Q in the
electron transport chain in the mitochondrial inner mem-
brane.126 This is in line with the enhanced fatty acid oxidation
pathway in daf-2 mutants, as described above.
Figure 8. Propionate metabolism. (Right) Heat map and (left) schematic overview of propionate metabolism enzymes. Numbers next to each heat
map row denote fold change (linear) in abundance for statistically signiﬁcant proteins. Proteins with signiﬁcantly changed abundance levels are
denoted *, p < 0.05; **, p < 0.005; and ***, p < 0.0005. (2) Propionyl-CoA carboxylase, (3) methylmalonyl-CoA racemase, and (4) methylmalonyl-
CoA isomerase.
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Interestingly, MAI-2, a member of the F1 ATPase inhibitor
(IF1) family, showed a modest but signiﬁcant upregulation in
daf-2 adults. IF1 inhibitor proteins prevent the deleterious
hydrolytic consumption of ATP by complex V under anoxic
conditions when the electrochemical gradient across the inner
membrane collapses.127 This ﬁnding is consistent with an
earlier report of elevated transcriptional expression of IF1
inhibitors in daf-2 mutants and dauers.23 Increased expression
of MAI-2 may, in part, explain the ability of daf-2 to withstand
prolonged hypoxic insult better.8
■ CONCLUSIONS
Decreased Gluconeogenic Flux in the Young Adult daf-2
Mutant Is Suggestive of Increased Malate Dismutation
We found increased levels of most glycolytic enzymes (with the
exception of pyruvate kinase) and gluconeogenic enzymes,
including PEPCK. Together with an experimentally conﬁrmed
increased ﬂux of carbon through the glyoxylate shunt and high
levels of the storage sugars glycogen and trehalose, it was
assumed gluconeogenic activity is high in the daf-2 mutant.
However, despite high PEPCK enzyme levels, a signiﬁcant
decrease of in vitro PEPCK activity was detected for the young
adult daf-2, implying reduced gluconeogenesis. In contrast,
pyruvate kinase activity was similar between daf-2 and the daf-
16;daf-2 reference, suggesting glycolytic ﬂux is not drastically
altered in daf-2. In the event pyruvate kinase activity would be a
limiting factor, the conversion of PEP into pyruvate is
prevented, favoring glucose production via gluconeogene-
sis.128−130 Alternatively, as was suggested by O’Riordan and
Burnell, PEPCK potentially acts in reverse, driving CO2 ﬁxation
via PEP and oxaloacetate with the subsequent formation of
malate via malate dehydrogenase, as is seen in parasitic
helminthes97 (green arrows in Figure 1). Although increased
levels of malate have been found in the daf-2 mutant,11 malate
synthesis is most likely also increased via the upregulated
glyoxylate shunt.
Helminths such as Fasciola hepatica and Ascaris suum are able
to survive under anaerobic conditions in their host environment
Figure 9. (A) Tyrosine catabolism. (Right) Heat map and (left) schematic overview of tyrosine catabolism enzymes. Numbers next to each heat map
row denote fold change (linear) in abundance for statistically signiﬁcant proteins. Proteins with signiﬁcantly changed abundance levels are denoted *,
p < 0.05; **, p < 0.005; and ***, p < 0.0005. (1) (Tyrosine/aspartate) transaminase, (2) p-hydroxyphenylpyruvate hydroxylase, (3) homogentisate
oxidase, (4) maleylacetoacetate isomerase, and (5) fumarylacetoacetate hydrolase. (B) BCAA catabolism. (1) Branched-chain aminotransferase, (2)
branched-chain α-keto acid decarboxylase complex, and (3) IVD-1, isovaryl-CoA dehydrogenase; B0250.5, 3-hydroxyisobutyrate dehydrogenase.
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by generating ATP via the malate dismutation pathway.131,132
The malate dismutation pathway appears to be conserved in C.
elegans and is thought to play an essential role in dauer energy
metabolism and survival.19,133 Furthermore, Rea and Johnson
hypothesized that a shift from aerobic to mitochondrial
anaerobic respiration underlies daf-2 longevity and possibly
most, if not all, other life-span extending mutations, including
Mit mutants.134 In this pathway, glycolytic phosphoenolpyr-
uvate is converted into oxaloacetate by PEPCK, which is then
further reduced by cytosolic malate dehydrogenase to produce
malate. Once malate is transported into (partially) anaerobically
functioning mitochondria, it is further catabolized to generate
ATP from the proton gradient generated across the inner
mitochondrial membrane by electron transport, but fumarate is
utilized as the terminal electron acceptor instead of O2,
producing succinate instead of H2O. We speculate the strong
increased abundance of the putative mitochondrial tricarbox-
ylate carrier K11H3.3 could be responsible for the increased
import of cytosolic malate into the mitochondrial matrix in
exchange for citrate (Figure 6b). As was noted earlier, strong
activation of the glyoxylate shunt in daf-2 mutants could also
constitute a considerable source of intramitochondrial malate to
drive anaerobic respiration. Although we were able to quantify
several enzymes involved in malate dismutation, including malic
enzyme (Y48B6A.12), ASC (C05C10.3), and STK subunits
(C50F7.4, F47B10.1, and F23H11.3), none of them showed
any signiﬁcant alteration in protein expression (data not
shown).
However, we detected a clear upregulation of all propionate
catabolism enzymes in daf-2. Propionate is one of the principal
waste products (along with acetate and succinate)135 of malate
dismutation and was previously found to be present in higher
levels in the daf-2 mutant.13 Lastly, the conspicuous down-
regulation of complex IV components but increases in
Figure 10. Mitochondrial respiratory chain. Schematic representation of the respiratory chain (Complexes I−IV) together with heat maps of
detected subunits. Numbers next to each heat map row denote fold change (linear) in abundance for statistically signiﬁcant proteins. Proteins with
signiﬁcantly changed abundance levels are denoted *, p < 0.05; **, p < 0.005; and ***, p < 0.0005. Green arrows indicate the possible alternative ﬂux
of electrons via rhodoquinone (RQ) (instead of ubiquinone, UQ) over complex II using fumarate as the ﬁnal electron acceptor. ETF, electron
transferring ﬂavoprotein; ETFDH, electron transferring ﬂavoprotein dehydrogenase.
Journal of Proteome Research Article
dx.doi.org/10.1021/pr401081b | J. Proteome Res. 2014, 13, 1938−19561950
complexes I−III could indicate that mitochondrial respiration
in daf-2 relies less on oxygen as the terminal electron acceptor
to maintain the proton gradient. Taken together, these results
support activation of the malate dismutation pathway in daf-2, a
hypothesis that merits further study.
daf-2 Shares Altered One-Carbon Metabolism with the
pept-1 Mutant
Protein expression of enzymes in THF anabolism and the SAM
biosynthetic pathway were increased and decreased in the daf-2
mutant, respectively. Interestingly, previous proteomic and
metabolomic analysis of the pept-1 mutant revealed a very
similar decrease in the abundance of one-carbon metabolism
enzymes, including S-adenosylmethionine synthase (SAMS-1)
and S-adenosylhomocysteine hydrolase (AHCY-1), and
changes in methionine (decreased) and homocysteine (in-
creased).12 pept-1 encodes an intestinal peptide transporter
required for the absorption of amino acids in form of di- and
tripeptides from the environment, and its mutation further
extends daf-2 lifespan by approximately 60%.136 In contrast
with our ﬁndings, however, the same group was unable to ﬁnd
these changes for the daf-2 mutant. Nevertheless, reduced
SAMS-1 protein levels in daf-2 have been reported before,67
and daf-2 is characterized as a strong transcriptional repression
of pept-1.39 SAMS-1 was previously discovered to be a mediator
of the DR response, possibly downstream of TOR signaling,
and is required for a normal protein synthesis rate.137,138 In
addition, metformin-induced lifespan extension in C. elegans
was recently shown to result from methionine restriction
following disruption of folate metabolism in the E. coli food
source.139 Therefore, one attractive hypothesis is that
alterations in the methionine cycle results in reduced protein
synthesis in the daf-2 mutant, the latter of which has been
experimentally conﬁrmed by us47 and others.140 By extension,
we postulate decreased protein synthesis in the pept-1 mutant
and metformin-treated C. elegans, which could conceivably
underlie their longevity phenotype.141−143 Moreover, because
RNAi knockdown of pept-1 results in a signiﬁcant decrease in
the intracellular pool of free amino acids, a concomitant
decrease in protein synthesis is to be expected.12,136
Altered Amino Acid Metabolism in the daf-2 Mutant
Several metabolomic proﬁling studies have revealed changes in
the metabolism of amino acids in the daf-2 mutant.11−13 In
particular, changes in BCAA metabolism have been linked to
daf-2, but it remains unclear how these changes contribute to
daf-2 longevity, if at all. In mammals, BCAAs (leucine in
particular) are well-known to stimulate protein synthesis
through activation of TOR (target of rapamycin) kinase.144
However, because we recently showed that protein synthesis is
repressed in the daf-2 mutant, such action by BCAAs would
thus have to be restricted to certain tissues, such as body-wall
muscles, which we have shown previouslty are preserved from
degradation in daf-2.47 More recently, increased levels of
aromatic amino acids (Phe and Tyr) and especially BCAA
degradation products, such as Glu, Ala, and C3 and C5
acylcarnitines, were found to be strongly associated with insulin
resistance and type 2 diabetes in humans.145 It was suggested
that accumulation of these incompletely oxidized intermediates
causes mitochondrial stress, leading to impaired insulin
action.146 It is therefore conceivable that the rationale for the
inhibition of BCAA catabolism in the daf-2 mutant is a (futile)
attempt to restore normal insulin/IGF-1 signaling levels. In
parallel, tyrosine was identiﬁed in C. elegans as a potent
antagonist of insulin signaling, promoting dauer formation and
inducing longevity (A. Ferguson, P. Hu, D. Kim, and A. Fisher,
personal communication), and enzymes of this pathway have
been associated with C. elegans longevity before.15,17,19,39,67,147
Similarly, the increased catabolism of tyrosine is conceivably
part of a feedback mechanism for restoration of normal insulin/
IGF-1 signaling. Finally, C3 and C5 acylcarnitines mainly arise
from the incomplete catabolism of propionate (following
BCAA degradation, Figure 8). Thus, increased expression of
propionate catabolism enzymes should further prevent
accumulation of these intermediates.
Does the daf-2 Metabolic Pattern Also Support Its Long
Lifespan?
Interestingly, attenuation of intermediary metabolism (glycol-
ysis, the TCA cycle, and gluconeogenesis)67,137,148−150 and the
electron transport chain15,151−153 has been reported to extend
life-span of daf-2 mutants signiﬁcantly further. This is
unexpected because expression of all these enzymes is increased
in response to reduced IIS. It has been suggested that activation
of metabolism is part of a compensatory mechanism triggered
by reduced IIS that antagonizes full life-span potential of daf-2
mutants.67 We additionally propose that further attenuation of
an already reduced metabolic rate could have an additive eﬀect
on daf-2 lifespan, perhaps at the cost of reduced metabolic
responsiveness to environmental triggers. Note, however, that
activation of the glyoxylate shunt (isocitrate lyase/malate
synthase, ICL-1) has been shown to be required for full life-
span extension in the daf-2 mutant17 as well as in ubiquinone-
defective clk-1,103 suggesting that increased activity of this
pathway is indispensable for IIS- or ETC-induced longevity.
In summary, our data suggests daf-2 mutant cells are
equipped with highly bioenergetic competent mitochondria and
a proﬁcient, partly rerouted metabolic network that makes
economical use of internal energy stores to maintain energy
homeostasis during its long life. A major challenge for the ﬁeld
will be to unravel the multiplicity of tissue-speciﬁc metabolic
changes and how these tissues in turn interact to achieve the
extensive physiological transformation induced by mutation in
daf-2. Ultimately, such detailed understanding of the altered
metabolism of C. elegans IIS mutants could also lead to
important insights into various insulin-related disease pathol-
ogies in humans such as diabetes and obesity as well as aging.
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